These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10342716)

  • 1. Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus.
    Harigai M; Hara M; Fukasawa C; Nakazawa S; Kawaguchi Y; Kamatani N; Kashiwazaki S
    Lupus; 1999; 8(3):227-33. PubMed ID: 10342716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus.
    Nagafuchi H; Shimoyama Y; Kashiwakura J; Takeno M; Sakane T; Suzuki N
    Clin Exp Rheumatol; 2003; 21(1):71-7. PubMed ID: 12673892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production.
    Desai-Mehta A; Lu L; Ramsey-Goldman R; Datta SK
    J Clin Invest; 1996 May; 97(9):2063-73. PubMed ID: 8621796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes.
    Koshy M; Berger D; Crow MK
    J Clin Invest; 1996 Aug; 98(3):826-37. PubMed ID: 8698875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism.
    Nakamura M; Tanaka Y; Satoh T; Kawai M; Hirakata M; Kaburaki J; Kawakami Y; Ikeda Y; Kuwana M
    Rheumatology (Oxford); 2006 Feb; 45(2):150-6. PubMed ID: 16188945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus.
    Bijl M; Horst G; Limburg PC; Kallenberg CG
    Ann Rheum Dis; 2001 May; 60(5):523-6. PubMed ID: 11302879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood lymphocytes in SLE--hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells.
    Devi BS; Van Noordin S; Krausz T; Davies KA
    J Autoimmun; 1998 Oct; 11(5):471-5. PubMed ID: 9802931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of CD40 on bone marrow CD34+ hematopoietic progenitor cells in patients with systemic lupus erythematosus: contribution to Fas-mediated apoptosis.
    Pyrovolaki K; Mavroudi I; Sidiropoulos P; Eliopoulos AG; Boumpas DT; Papadaki HA
    Arthritis Rheum; 2009 Feb; 60(2):543-52. PubMed ID: 19180486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
    Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera.
    Vakkalanka RK; Woo C; Kirou KA; Koshy M; Berger D; Crow MK
    Arthritis Rheum; 1999 May; 42(5):871-81. PubMed ID: 10323442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased frequency of circulating follicular helper T cells in lupus patients is associated with autoantibody production in a CD40L-dependent manner.
    Xu H; Liu J; Cui X; Zuo Y; Zhang Z; Li Y; Tao R; Li Y; Pang J
    Cell Immunol; 2015 May; 295(1):46-51. PubMed ID: 25748125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD40 antibody KPL-404 inhibits T cell-mediated activation of B cells from healthy donors and autoimmune patients.
    Marken J; Muralidharan S; Giltiay NV
    Arthritis Res Ther; 2021 Jan; 23(1):5. PubMed ID: 33407802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common SNP in the CD40 region is associated with systemic lupus erythematosus and correlates with altered CD40 expression: implications for the pathogenesis.
    Vazgiourakis VM; Zervou MI; Choulaki C; Bertsias G; Melissourgaki M; Yilmaz N; Sidiropoulos P; Plant D; Trouw LA; Toes RE; Kardassis D; Yavuz S; Boumpas DT; Goulielmos GN
    Ann Rheum Dis; 2011 Dec; 70(12):2184-90. PubMed ID: 21914625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
    Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The soluble CD40 ligand sCD154 in systemic lupus erythematosus.
    Kato K; Santana-Sahagún E; Rassenti LZ; Weisman MH; Tamura N; Kobayashi S; Hashimoto H; Kipps TJ
    J Clin Invest; 1999 Oct; 104(7):947-55. PubMed ID: 10510335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus.
    Blossom S; Chu EB; Weigle WO; Gilbert KM
    J Immunol; 1997 Nov; 159(9):4580-6. PubMed ID: 9379059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune lpr/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses.
    Ma J; Xu J; Madaio MP; Peng Q; Zhang J; Grewal IS; Flavell RA; Craft J
    J Immunol; 1996 Jul; 157(1):417-26. PubMed ID: 8683147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions.
    Grammer AC; Slota R; Fischer R; Gur H; Girschick H; Yarboro C; Illei GG; Lipsky PE
    J Clin Invest; 2003 Nov; 112(10):1506-20. PubMed ID: 14617752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response.
    Early GS; Zhao W; Burns CM
    J Immunol; 1996 Oct; 157(7):3159-64. PubMed ID: 8816428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro induction of IgG anti-DNA antibody from high density B cells of systemic lupus erythematosus patients by an HLA DR-restricted T cell clone.
    Murakami M; Kumagai S; Sugita M; Iwai K; Imura H
    Clin Exp Immunol; 1992 Nov; 90(2):245-50. PubMed ID: 1424281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.